Cargando…
Combined phospholipids adjuvant augments anti-tumor immune responses through activated tumor-associated dendritic cells
Dendritic cells (DCs) can initiate both naïve and memory T cell activation, as the most potent antigen-presenting cells. For efficient anti-tumor immunity, it is essential to enhance the anti-tumoral activity of tumor-associated DCs (TADCs) or to potently restrain TADCs so that they remain immuno-st...
Autores principales: | Shui, Yifang, Hu, Xin, Hirano, Hiroshi, Tsukamoto, Hirotake, Guo, Wen-Zhi, Hasumi, Kenichiro, Ijima, Fumihiro, Fujino, Masayuki, Li, Xiao-Kang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018555/ https://www.ncbi.nlm.nih.gov/pubmed/36893559 http://dx.doi.org/10.1016/j.neo.2023.100893 |
Ejemplares similares
-
Augmentation and Suppression of Release of Tumor Necrosis Factor from Macrophages by Negatively Charged Phospholipids
por: Yui, Satoru, et al.
Publicado: (1991) -
Dendritic Cells as Adjuvants for Immune-mediated Resistance to Tumors
por: Schuler, G., et al.
Publicado: (1997) -
Immune‐suppressive effects of interleukin‐6 on T‐cell‐mediated anti‐tumor immunity
por: Tsukamoto, Hirotake, et al.
Publicado: (2017) -
Generation and characterization of regulatory dendritic cells derived from murine induced pluripotent stem cells
por: Zhang, Qi, et al.
Publicado: (2014) -
Combined TLR2/4-Activated Dendritic/Tumor Cell Fusions Induce Augmented Cytotoxic T Lymphocytes
por: Koido, Shigeo, et al.
Publicado: (2013)